The global defibrillator market size was valued at USD 15.18 billion in 2025 and is projected to grow from USD 16.21 billion in 2026 to USD 27.46 billion by 2034, registering a CAGR of 6.81% during the forecast period from 2026 to 2034. North America dominated the defibrillator market with a market share of 38.6% in 2025.
A defibrillator is a medical device that delivers a controlled electrical shock to the heart to help restore a normal heart rhythm during life-threatening cardiac conditions such as sudden cardiac arrest. Defibrillators are available in different types, including automated external defibrillators (AEDs), implantable cardioverter-defibrillators (ICDs), and manual devices. They are widely used in hospitals, emergency services, clinics, and public spaces to provide rapid cardiac intervention.
Download a Free Sample To learn more about this report,
Growing Adoption of Compact and Portable AEDs
The defibrillator market is moving toward smaller automated external defibrillators that can be carried in vehicles, backpacks, workplaces, and recreational settings rather than remaining limited to fixed public locations. Compact devices can shorten the distance between a cardiac-arrest victim and available defibrillation, particularly where conventional wall-mounted AEDs are difficult to access quickly. Improvements in battery, electrode, and electronic design are supporting this transition. Portable AED development is therefore becoming an important part of defibrillator market trends.
In July 2026, St John launched the Pocket AED, a compact automated external defibrillator approximately the size of a soft-drink can and weighing less than 700 grams, making it suitable for backpacks, vehicles, first-aid kits, and mobile emergency-response applications.
Increasing Development of Patch-Based Wearable Defibrillators
Wearable defibrillation is evolving from relatively bulky garment-based systems toward compact patch-style devices designed to provide continuous protection outside hospitals. These devices continuously monitor cardiac rhythms and can automatically deliver treatment when life-threatening arrhythmias are detected. Patch-based designs can improve mobility and potentially increase acceptance among patients who need temporary protection but are not immediate candidates for implanted devices. Wearable innovation is consequently expanding the defibrillator industry toward more patient-centered cardiac protection.
In April 2025, Element Science received FDA approval for its Jewel Patch Wearable Cardioverter Defibrillator for adults at risk of sudden cardiac arrest. The approval covers the Jewel device together with its mobile application, cloud platform, clinical portal, and associated software ecosystem.
High Burden of Out-of-Hospital Cardiac Arrest Increases AED Requirements
Sudden cardiac arrest requires immediate intervention because survival probability falls rapidly when defibrillation is delayed. Wider availability of AEDs in workplaces, transportation facilities, educational institutions, sports venues, and other public spaces can allow bystanders to deliver a shock before emergency medical personnel arrive. However, public-access AED utilization remains relatively limited, leaving considerable scope for deployment. The need for faster emergency defibrillation is therefore strengthening defibrillator market demand.
In October 2025, the American Heart Association reported approximately 263,711 EMS-treated non-traumatic out-of-hospital cardiac arrests during 2024. Only 12.6% of people experiencing cardiac arrest in public had an AED applied by a lay rescuer, highlighting the remaining gap in public-access defibrillation.
Device and Electrode Recalls Increase Reliability Concerns
Defibrillators must function reliably during rare but immediately life-threatening emergencies, making hardware, battery, software, and electrode failures particularly serious. Manufacturers therefore face strict quality controls and post-market monitoring requirements, while recalls can require device inspections, component replacements, customer notifications, and additional regulatory work. Reliability concerns can increase ownership and compliance burdens for healthcare providers. Product-quality issues can consequently restrain defibrillator market growth.
In January 2026, Physio-Control initiated a recall involving Infant/Child Reduced Energy Defibrillator Electrodes used with compatible automated external defibrillators. The FDA subsequently classified the action as a Class II recall in March 2026 under recall number Z-1544-2026.
Expansion of Wearable Protection During Temporary Cardiac Risk
Patients with newly diagnosed cardiomyopathy or other temporary high-risk cardiac conditions may need protection against sudden cardiac death while physicians assess recovery and determine whether an implantable cardioverter-defibrillator is necessary. Wearable devices provide continuous monitoring and automatic treatment without requiring immediate surgery. This creates a distinct commercial opportunity between conventional external AEDs and permanent implanted systems. Temporary cardiac-risk management can therefore help suppliers increase defibrillator market share.
In November 2025, Kestra Medical Technologies reported that its ACE-PAS study of the ASSURE Wearable Cardioverter Defibrillator enrolled more than 20,000 patients, making it the largest prospective wearable cardioverter-defibrillator study conducted to date.
Improving Implantable Defibrillator Lead Durability
Implantable cardioverter-defibrillator leads must remain functional for years while repeatedly experiencing bending, twisting, cardiac motion, and other mechanical stresses inside the body. Lead fatigue or insulation deterioration can interfere with sensing and potentially affect delivery of life-saving therapy. Manufacturers must therefore improve materials and mechanical design without increasing lead dimensions or making implantation more difficult. Long-term lead reliability remains a major technical challenge as defibrillator market size expands across implantable cardiac-rhythm-management applications.
In February 2026, Boston Scientific received FDA approval for multiple design changes to its EMBLEM S-ICD electrode, including improvements in fatigue endurance, changes to insulation material and supplier, and updates to several subcomponents.
Implantable Cardioverter Defibrillators (ICDs) Segment Dominated the Market with 61.7% Share in 2025
The implantable cardioverter defibrillators (ICDs) segment dominated the global defibrillator market with a 61.7% market share in 2025, valued at USD 9.37 billion. The segment's leadership is supported by the established role of ICDs in continuously monitoring cardiac rhythms and delivering corrective electrical therapy when life-threatening arrhythmias are detected. Growing awareness of sudden cardiac arrest risks and advances in device technology are supporting the use of ICDs among patients requiring long-term protection.
External defibrillators continue to play an important role in emergency cardiac care across hospitals, ambulances, public locations, and other healthcare environments. Improvements in portability, automated operation, ease of use, and connectivity are helping expand access to rapid defibrillation during cardiac emergencies.
Request Customizationto receive a tailored report.
Home Healthcare Segment is Projected to Register the Fastest Growth at a CAGR of 8.73%
The home healthcare segment is projected to register the fastest growth at a CAGR of 8.73% during the forecast period. Increasing interest in decentralized healthcare and remote patient management is supporting the use of cardiac monitoring and emergency-care technologies outside traditional hospital settings. Advances in compact device design and growing awareness of early intervention are also contributing to opportunities for defibrillator use in home-based care environments.
Hospitals, pre-hospital services, public access locations, alternate care facilities, and other healthcare settings continue to represent important areas of defibrillator demand. Expanding emergency response infrastructure and greater availability of automated external defibrillators are helping improve access to timely cardiac intervention in both clinical and community environments.
Speak to an Analystto discuss market opportunities.
The North American defibrillator market accounted for 38.6% of the global market, reaching USD 5.86 billion in 2025, and is projected to grow at a CAGR of 6.74% during the forecast period. The region's leading position is supported by the high prevalence of cardiovascular diseases, established emergency medical infrastructure, widespread availability of advanced cardiac care, and increasing adoption of automated external defibrillators across hospitals, public facilities, and other emergency response settings.
The United States represents a major market in North America. Strong healthcare infrastructure, increasing demand for emergency cardiac care, widespread adoption of AEDs, and continued technological advancements in defibrillation devices support market development.
Canada's established healthcare system, increasing focus on emergency cardiac response, and growing availability of defibrillation equipment across healthcare and public settings continue to support market growth.
Unlock Regional Insightsto access country-level data, & regional trends.
The European defibrillator market accounted for 27.4% of the global market, reaching USD 4.16 billion in 2025, and is expected to register a CAGR of 6.58% during the forecast period. Rising cardiovascular disease burden, increasing investments in emergency medical infrastructure, growing awareness of sudden cardiac arrest response, and adoption of technologically advanced defibrillators continue to support regional growth.
Germany represents a major European market. Its advanced healthcare infrastructure, strong emergency medical services, and increasing adoption of modern cardiac care technologies continue to support defibrillator market development.
The United Kingdom's focus on emergency cardiac response, increasing availability of AEDs in public locations, and continued development of cardiovascular care infrastructure support market growth.
The Asia Pacific defibrillator market accounted for 22.8% of the global market, reaching USD 3.46 billion in 2025, and is projected to grow at a CAGR of 8.91% during the forecast period. The region records the fastest growth among the listed markets, driven by rising cardiovascular disease incidence, expanding healthcare infrastructure, increasing healthcare expenditure, greater awareness of sudden cardiac arrest, and growing adoption of advanced emergency medical technologies.
China represents a major market within the Asia Pacific. Expanding healthcare infrastructure, increasing cardiovascular disease burden, and growing investments in emergency medical equipment continue to drive demand for defibrillators.
India's expanding healthcare infrastructure, rising awareness of cardiac emergencies, increasing healthcare investments, and growing availability of emergency medical equipment continue to create opportunities for defibrillator market growth.
Japan's aging population, advanced healthcare infrastructure, high focus on cardiovascular care, and established deployment of AEDs across public and healthcare settings continue to support market development.
Latin America's defibrillator market accounted for 6.3% of the global market, reaching USD 0.96 billion in 2025, and is expected to grow at a CAGR of 6.89% during the forecast period. Increasing cardiovascular disease awareness, healthcare infrastructure development, growing emergency medical requirements, and expanding access to cardiac care technologies continue to support regional market growth.
Brazil represents a major regional market. Its large healthcare system, rising focus on cardiovascular disease management, and increasing demand for emergency medical equipment continue to create opportunities for defibrillator manufacturers.
The Middle East & Africa defibrillator market accounted for 4.9% of the global market, reaching USD 0.74 billion in 2025, and is anticipated to grow at a CAGR of 6.21% during the forecast period. Healthcare infrastructure development, increasing cardiovascular disease awareness, rising healthcare investments, and growing adoption of emergency cardiac care technologies continue to support regional market development.
The UAE's advanced healthcare infrastructure, investments in emergency medical services, and increasing focus on cardiovascular care continue to support demand for defibrillation equipment.
Saudi Arabia's expanding healthcare infrastructure, increasing investment in emergency care, and growing focus on cardiovascular disease management continue to strengthen demand for defibrillators.
The global pool tables market is highly competitive, with leading billiards equipment manufacturers competing through premium craftsmanship, innovative table designs, high-quality playing surfaces, customizable finishes, and products tailored to residential, commercial, hospitality, and professional applications. The major players in the market include American Heritage Billiards, Predator Group, Imperial International, Blatt Billiards, Brunswick Billiards, Gabriels Billiards, Legacy Billiards, Olhausen Billiard Mfg. Inc., Riley England, Valley Dynamo Inc., Garlando, Alcocks, Hathaway, Plank and Hide, Liberty Games, and others.
Industry participants are focusing on developing durable and aesthetically appealing pool tables with improved slate construction, precision leveling systems, advanced cushion technology, customizable finishes, and space-efficient designs. Companies are investing in premium materials, modern table aesthetics, convertible dining and game tables, compact models, and customized solutions for homes, clubs, hotels, entertainment venues, and professional tournaments. Growing consumer interest in recreational activities, home entertainment, luxury game rooms, and competitive billiards is also encouraging manufacturers to broaden their product portfolios and strengthen retail and online distribution channels.
Brunswick Billiards is one of the established names in the global billiards industry, offering a broad range of pool tables designed for residential, commercial, and recreational environments. The company is recognized for its traditional craftsmanship, premium materials, precision engineering, and diverse designs that combine playing performance with furniture-style aesthetics.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Artificial Lung Market Size, Share, Growth, Analysis, 2034
Bronchoscopes Market Size, Share, Growth, Analysis, Report, 2034
Aesthetic Threads Market Size, Share, Growth, Forecast, 2034
Middle East And Africa Diabetes Devices Market Size and Forecast 2034
Bladder Scanners Market Size, Share, Growth, Forecast, 2034
Japan Dialyzer Market Size, Top Share, Demand And Forecast to 2034
We are featured on:
sales@straitsresearch.com